(Q44471917)

3 December 2017

DNA repair enzymes and cytotoxic effects of temozolomide: comparative studies between tumor cells and normal cells of the immune system (English)

1 reference

3 December 2017

0 references

0 references

E Pagani

1

1 reference

3 December 2017

R Pepponi

2

1 reference

3 December 2017

M P Fuggetta

3

1 reference

3 December 2017

S P Prete

4

1 reference

3 December 2017

M Turriziani

5

1 reference

3 December 2017

L Bonmassar

6

1 reference

3 December 2017

P M Lacal

7

1 reference

3 December 2017

S Falcinelli

8

1 reference

3 December 2017

F Passarelli

9

1 reference

3 December 2017

F Guadagni

10

1 reference

3 December 2017

E Alvino

11

1 reference

3 December 2017

S D'Atri

12

1 reference

3 December 2017

1 April 2003

1 reference

3 December 2017

Journal of Chemotherapy

1 reference

3 December 2017

15

1 reference

3 December 2017

173-183

1 reference

3 December 2017

2

1 reference

Endogenous mutagens and the causes of aging and cancer

3 December 2017

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.173

Clinical relevance of MGMT in the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.173

Mismatch repair defects in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.173

Strand-specific mismatch repair in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.173

DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.173

Building bridges in cancer: mismatch repair and microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.173

Emerging pathways in colorectal-cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.173

Distinction between familial and sporadic forms of colorectal cancer showing DNA microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.173

An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.173

Competency in mismatch repair prohibits clonal expansion of cancer cells treated with N-methyl-N'-nitro-N-nitrosoguanidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.173

Role of postreplicative DNA mismatch repair in the cytotoxic action of thioguanine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.173

Cisplatin and adriamycin resistance are associated with MutLalpha and mismatch repair deficiency in an ovarian tumor cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.173

Phase II trial of temozolomide in low-grade non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.173

Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.173

Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.173

Temozolomide: a novel oral alkylating agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.173

Temozolomide: a new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.173

Drug Induced Modulation of Immune Responses in Mice: Effects of 5-(3,3-Dimethyl-1-Triazeno)-Imidazole-4-Carboxamide (DTIC) and Cyclophosphayide (CY)

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.173

The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.173

Isolation of a human lymphoblastoid line heterozygous at the thymidine kinase locus: Possibility for a rapid human cell mutation assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.173

Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.173

Increased O6-alkylguanine alkyltransferase activity in Chinese hamster V79 cells following selection with chloroethylating agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.173

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.173

Untreated or drug-treated tumor cells are differentially recognized by allogeneic lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.173

Importance of the DNA repair enzyme O6-alkyl guanine alkyltransferase (AT) in cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.173

Pretreatment of human colon tumor cells with DNA methylating agents inhibits their ability to repair chloroethyl monoadducts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.173

Sequential administration of varying doses of dacarbazine and fotemustine in advanced malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.173

Sequential administration of dacarbazine and fotemustine in patients with disseminated malignant melanoma--an effective combination with unexpected toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.173

Genetic chemoprotection with mutant O6-alkylguanine-DNA-alkyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.173

A role for mismatch repair in production of chromosome aberrations by methylating agents in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.173

Self-destruction and tolerance in resistance of mammalian cells to alkylation damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.173

Cytokine-induced expression of CD1b molecules by peripheral blood monocytes: influence of 3'-azido-3'-deoxythymidine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.173

Glycolipid targets of CD1-mediated T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.173

Immunological alteration of leukemic cells in vivo after treatment with an antitumor drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.173

Chemical xenogenization of murine lymphoma cells with triazene derivatives: immunotoxicological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2003.15.2.173

10.1179/JOC.2003.15.2.173

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference